| Bioactivity | 6-Raloxifene-β-D-glucopyranoside, a derivative of Raloxifene, is a benzothiophene glucuronidated at the 6' postion. 6-Raloxifene-β-D-glucopyranoside is a selective and orally active estrogen receptor antagonist. 6-Raloxifene-β-D-glucopyranoside can be used for inhibiting bone loss and resorption, and lowering lipid levels. 6'-Raloxifene-β-D-glucopyranoside, compound Ia, is extracted from patent US5567820A[1]. |
| Target | IC50: estrogen receptor |
| Name | 6-Raloxifene-β-D-glucopyranoside |
| CAS | 334758-18-8 |
| Formula | C34H37NO9S |
| Molar Mass | 635.72 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jeffrey A. Dodge, et al. Glucopyranoside benzothiophenes. Patent US5567820A. |
6-Raloxifene-β-D-glucopyranoside
CAS: 334758-18-8 F: C34H37NO9S W: 635.72
6-Raloxifene-β-D-glucopyranoside, a derivative ofRaloxifene, is a benzothiophene glucuronidated at the 6' postion. 6-Ra
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.